Thymosin Alpha 1

TA 1 Thymosin Alpha-1 (TA-1) is a 28-amino acid peptide that acts as a potent immunomodulator, primarily by promoting the maturation and differentiation of T cells and enhancing the activity of natural killer (NK) cells.

It functions by stimulating the production of critical immune signaling molecules, such as interleukin-2 (IL-2) and interferon-gamma (IFN-γ), while simultaneously regulating inflammatory responses by inhibiting pro-inflammatory cytokines and promoting anti-inflammatory ones like IL-10.

Key benefits and clinical applications include:

• Antiviral Defense: It enhances resistance to chronic viral infections, including Hepatitis B and C, HIV, and potentially severe respiratory illnesses like COVID-19, by boosting antiviral immune surveillance.
• Autoimmune Regulation: TA-1 helps rebalance immune dysfunction in conditions such as rheumatoid arthritis, multiple sclerosis, and Hashimoto’s thyroiditis by promoting regulatory T-cell activity and reducing excessive inflammation.
• Cancer Support: It is used as an adjuvant in cancer therapy to enhance the body’s anti-tumor immune response, showing synergistic effects when combined with chemotherapy or immune checkpoint inhibitors.
• Immune Restoration: It aids in reversing immunosuppression caused by chemotherapy, aging, or chronic conditions like long COVID and chronic fatigue syndrome, improving overall immune resilience and recovery from infections.